Knockout of NRF2 triggers prostate cancer cells death through ROS modulation and sensitizes to cisplatin
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cellular Biochemistry"
DOI: 10.1002/jcb.30333
Abstract: Prostate cancer (PCa) represents the second most common cancer in men and affects millions worldwide. Chemotherapy is a common treatment for PCa but the development of resistance is often a problem during therapy. NRF2 (nuclear… read more here.
Keywords: cancer; prostate cancer; knockout nrf2; knockout ... See more keywords